CHIH-YUAN WANG, Doctor
Department of Internal Medicine, National Taiwan University Hospital
7
7
3
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dusan Kocovic, MD
Main Line Health Center/Lankenau Hospital, Wynnewood, PA
Shared therapeutic areas:
Lawrence Czer, MD
Cedars-Sinai Medical Center, Los Angeles, CA
Shared therapeutic areas:
Joseph Rogers, MD
Duke University Medical Center, Durham, NC
Shared therapeutic areas:
Daniel Landa, MD
St. Jude Hospital, Fullerton, CA
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Zi-Juan Xu, MD
Sutter Memorial Hospital, Sacramento, CA
Shared therapeutic areas:
John P. McKenzie III, MD
Glendale Memorial Hospital and Medical Center, Glendale, CA
Shared therapeutic areas:
Hamang Patel, MD
Ochsner Health System
Shared therapeutic areas:
Peter Fattal, MD
MidMichigan Physicians Group, Midland, MI
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
Early Detection of Autoimmune Thyroid Heart Disease Via Urinary Exosomal Proteins
Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3
Long Period Observation of Biochemical Survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases
Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
All 7 trials loaded